Home Strains Research Conditions Breeders Compare Explorer Blog

Command Palette

Search for a command to run...

BudProfiles

The world's most comprehensive cannabis strain directory, backed by scientific research.

11,121 strains · 12,304 studies · 268 breeders

Combined tetrahydrocannabinol and cannabidiol to treat pain — 2019 Review/Other | BudProfiles

Home

Studies

Combined tetrahydrocannabinol and cannabidiol to t...

PositiveReview/Other2019

Combined tetrahydrocannabinol and cannabidiol to treat pain in epidermolysis bullosa: a report of three cases

View Study

Classification Results

AI Classification

Positive

Fine-tuned Classification

Positive

Conditions Studied

Epidermolysis bullosa

Related Studies

Positive

Cannabidiol-Loaded Nanostructured Lipid Carriers (NLCs) for Dermal Delivery: Enhancement of Photostability, Cell Viability, and Anti-Inflammatory Activity

2023·Review/Other

Positive

Cannabinol: History, Syntheses, and Biological Profile of the Greatest “Minor” Cannabinoid

2022·Review/Other

Positive

Cannabinoids for the Treatment of Dermatologic Conditions

2022·Review/Other

Inconclusive

The C4EB study-Transvamix (10% THC / 5% CBD) to treat chronic pain in epidermolysis bullosa: A protocol for an explorative randomized, placebo controlled, and double blind intervention crossover study

2022·Double Blind Clinical Trial

Negative

Efficacy and safety of paediatric medicinal cannabis use: A scoping review

2021·Review/Other

Positive

Cannabinoid use and effects in patients with epidermolysis bullosa: an international cross-sectional survey study

2021·Review/Other

Cannabinoids

Pharma THC:CBD

Organ Systems

Integumentary System

Study Details

Type: Review/Other
Year: 2019
Study ID: #2019133